Désirée Van Der Heijde, MD, PhD, a Key Driver of Treatment Advances - Page 4 of 6 - The Rheumatologist
Upadacitinib doubles ASAS 40 response vs. placebo in ankylosing spondylitis | MDedge Rheumatology
Prof.dr. D.M.F.M. (Désirée) van der Heijde (https://www.narcis.nl)
Upadacitinib improves signs, symptoms in patients with active AS
BE MOBILE 2: Bimekizumab in patients with active ankylosing spondylitis
AxSpA eller ikke axSpA – det er spørsmålet
PDF) Effects of baricitinib on radiographic progression of structural joint damage at 1 year in patients with rheumatoid arthritis and an inadequate response to conventional synthetic Disease-Modifying antirheumatic drugs
EULAR 2022 | The BE MOBILE 1 and 2 trials of bimekizumab in axSpA | rheumatology.medicinematters.com
Désirée Van Der Heijde, MD, PhD, a Key Driver of Treatment Advances - The Rheumatologist
Psoriatic Arthritis Workshop OMERACT May 14 th, 2004 Steering Committee Dafna Gladman, Philip Mease, Gerald Krueger, Désirée van der Heijde, Christian. - ppt download
Désirée van der Heijde: H-index & Awards - Academic Profile | Research.com
Profile - ASAS
Nieuwe voorzitter van de Ruggesteun bekend | Désirée van der Heijde is de nieuwe voorzitter van de Ruggesteun. Zij volgt Ludy Nijsten op die in juli overleed. In aanloop naar de inzamelingsactie...
Assessment in Ankylosing Spondylitis International Working Group/Spondylitis Association of America recommendations for conducting clinical trials in ankylosing spondylitis - van der Heijde - 2005 - Arthritis & Rheumatism - Wiley Online Library
Dies Natalisviering 2012, met uitreiking van eredoctoraten-10320 | Beeldbank
Désirée van der Heijde - Leiden University
Eredoctoraat voor LUMC-hoogleraar Désirée van der Heijde | LUMC
Désirée van der Heijde - Professor of Rheumatology - Leiden University Medical Center | LinkedIn
Désirée Van Der Heijde, MD, PhD, a Key Driver of Treatment Advances - Page 3 of 6 - The Rheumatologist
ADARRC 2016 - Interview with Speaker: Désirée van der Heijde, MD, PhD, The Netherlands - YouTube
Instrument development. ASDAS score with Desirée Van der Heijde - YouTube
Uncertainty common for those treating patients with non-radiographic axial spondyloarthritis - ACR Convergence Today
Updated axial SpA recommendations include IL-17 inhibitors | PM360
Ook radio-dj Desiree van der Heiden naar PowNed - Planetzone
Joachim Sieper, Désirée van der Heijde, Maxime Dougados, L Steve Brown,Frederic Lavie, Aileen L Pangan Ann Rheum Dis 2012;71: doi: /annrheumdis ppt download
